SIRT1 and SIRT6 signaling pathways in cardiovascular disease protection

N D'Onofrio, L Servillo, ML Balestrieri - Antioxidants & redox …, 2018 - liebertpub.com
Significance: Oxidative stress represents the common hallmark of pathological conditions
associated with cardiovascular disease (CVD), including atherosclerosis, heart failure …

[HTML][HTML] Sirtuins in vascular diseases: emerging roles and therapeutic potential

N D'Onofrio, M Vitiello, R Casale, L Servillo… - … et Biophysica Acta (BBA …, 2015 - Elsevier
Abstract Silent information regulator-2 (Sir-2) proteins, or sirtuins, are a highly conserved
protein family of histone deacetylases that promote longevity by mediating many of the …

GLP-1 receptor agonists-SGLT-2 inhibitors combination therapy and cardiovascular events after acute myocardial infarction: an observational study in patients with …

R Marfella, F Prattichizzo, C Sardu… - Cardiovascular …, 2024 - Springer
Background Few studies explored the effect of the combination of glucose sodium-
cotransporter-2 inhibitors (SGLT-2i) and glucagon-like peptide-1 receptor agonists (GLP …

MicroRNA‐33 and SIRT1 influence the coronary thrombus burden in hyperglycemic STEMI patients

N D'Onofrio, C Sardu, P Paolisso… - Journal of Cellular …, 2020 - Wiley Online Library
Primary percutaneous coronary intervention (PPCI) is a pivotal treatment in ST‐segment
elevation myocardial infarction (STEMI) patients. However, in hyperglycemic‐STEMI …

SIRT1 as a therapeutic target in diabetic complications

J Strycharz, Z Rygielska, E Swiderska… - Current medicinal …, 2018 - ingentaconnect.com
Background: Sirtuin1 is an epigenetic enzyme involved in histone and nonhistone protein
deacetylation. It acts primarily as a metabolic sensor, which responses to changing energy …

[HTML][HTML] Glycaemic control in people with diabetes following acute myocardial infarction

H Esdaile, N Hill, J Mayet, N Oliver - Diabetes research and clinical …, 2023 - Elsevier
Diabetes is a highly prevalent disease associated with considerable cardiovascular end
organ damage and mortality. Despite significant changes to the management of acute …

Fasting stress hyperglycemia ratio and in-hospital mortality after acute myocardial infarction in patients with different glucose metabolism status: results from China …

R Fu, K Cui, J Yang, H Xu, D Yin, W Song… - Diabetes Research and …, 2023 - Elsevier
Aims To evaluate the predictive value of fasting stress hyperglycemia ratio (SHR) for in-
hospital mortality in patients with acute myocardial infarction (AMI) under different glucose …

Stress induced hyperglycemia in the context of acute coronary syndrome: definitions, interventions, and underlying mechanisms

M Li, G Chen, Y Feng, X He - Frontiers in Cardiovascular Medicine, 2021 - frontiersin.org
Elevation of glucose level in response to acute coronary syndrome (ACS) has been
recognized as stress induced hyperglycemia (SIH). Plenty of clinical studies have …

Enhanced inflammation is a marker for risk of post-infarct ventricular dysfunction and heart failure

I Świątkiewicz, P Magielski, J Kubica… - International journal of …, 2020 - mdpi.com
Acute ST-segment elevation myocardial infarction (STEMI) activates inflammation that can
contribute to left ventricular systolic dysfunction (LVSD) and heart failure (HF). The objective …

Perindopril and a galectin-3 inhibitor improve ischemic heart failure in rabbits by reducing gal-3 expression and myocardial fibrosis

S Li, S Li, X Hao, Y Zhang, W Deng - Frontiers in physiology, 2019 - frontiersin.org
Objective: Ventricular remodeling is considered the basis of heart failure and is involved in
myocardial fibrosis. This study aimed to assess perindopril and a galectin-3 inhibitor …